News
10-23-2024, 06:06 PM
Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published by The BMJ today.
More... (https://www.news-medical.net/news/20241023/Multigene-RNA-signature-enhances-treatment-strategies-for-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20241023/Multigene-RNA-signature-enhances-treatment-strategies-for-triple-negative-breast-cancer.aspx)